Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Shwachman-Diamond syndrome

Orpha number ORPHA811
Synonym(s) Congenital lipomatosis of pancreas
Prevalence Unknown
Inheritance
  • Autosomal recessive
Age of onset Childhood
ICD-10
  • D61.0
OMIM
UMLS -
MeSH -
MedDRA
  • 10067940
SNOMED CT
  • 89454001

Summary

Shwachman-Diamond syndrome is marked by the association of an haematological defect with a dysmorphic syndrome characterised by lipomatosis of the pancreas resulting in external pancreatic insufficiency. This disease is very rare, with no more than a hundred cases reported in France. Other clinical signs include cutaneous effects (ichtyosis), bone defects (metaphyseal dysostosis, pectus carinatum), and psychomotor retardation. Magnetic resonance imaging (MRI) reveals a typical hyposignal in T2. Neutropaenia with deficient chemotaxis together with moderate thrombopaenia and anaemia and increased levels of foetal haemoglobulin have also been noted. This central haematological disturbance worsens and evolves towards aplasia in 25% of cases. Despite some similarities with Pearson syndrome, Shwachman-Diamond disease cannot be explained by mitochondrial DNA defects. Mutations occurring in the ubiquitous SBDS gene, located on chromosome 7, are found in most patients. The functions of the causative gene are highly polymorphic, making it difficult to explain the complex clinical picture. As long as neutropaenia is moderate and asymptomatic, patient management should be nutritional (pancreatic enzyme, nutritional and vitamin support). Hematopoietic growth factor (granulocyte colony-stimulating factor, G-CSF) therapy is sometimes beneficial. Patients affected by this syndrome are at increased risk of secondary leukaemia (principally acute myeloblastic leukaemia type FAB 5 or 6) or a myelodysplastic syndrome with cytological abnormalities (in particular, clonal cytological abnormalities frequently affecting chromosome 7). In cases where the disease evolves towards medular aplasia or malignant transformation, bone marrow transplant is required.

Expert reviewer(s)

  • Dr Jean DONADIEU

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Emergency guidelines
  • FR (2010,pdf)
  • ES (2009,pdf)
  • IT (2012,pdf)
Clinical genetics review
  • EN (2008)
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.